Gastrointestinal Therapeutics Market Share Insights | Global Demand & Trends analysis | Forecast

Felton, Calif., USA, Jan. 29, 2021 — /EPR Network/ —

The global Gastrointestinal Therapeutics Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

Global Gastrointestinal Therapeutics Market is anticipated to reach USD 65.1 billion by 2025. The market is anticipated to rise at a healthy growth rate in the years to come. Gastrointestinal disorders are medical situations associated with the digestive system that disturb the small & large intestine, colon, and rectum.

Key Players:

  • Abbott Laboratories
  • Allergan plc
  • AstraZeneca
  • Bayer AG
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals
  • Takeda Pharmaceuticals
  • Valeant Pharmaceuticals
  • Pfizer
  • AbbVie, Inc.

Request free sample to get a complete analysis of top-performing companies @

Growth Drivers:

The factors that propel the growth of market comprise the growing healthcare spending, increasing geriatric population, rising prevalence of gastrointestinal disease due to additional numbers of clinical trials, unhealthy dietary habits. On the other hand, the high competition among several key players to lead the market may ultimately rule the price attrition, and hamper the growth of market. However, these Gastro intestinal therapeutics have side effects, such as they have a low diagnosis rates, and stern rules for the approval of drugs. These factors will limit the growth of market in the years to come. The market is anticipated to grow at a significant CAGR of 6.6% in the upcoming period.

Application Outlook:

  • Ulcerative Colitis
  • Crohn’s Disease
  • GERD

Type Outlook:

  • Branded
    • Aminosalicylates
    • Antacids
    • Enzyme Replacement Therapies
    • Proton Pump Inhibitors
    • Laxatives
    • Antiemetics
    • H2 Antagonists
    • Antidiarrheals
    • Biologics
  • Generics

Route of Administration Outlook:

  • Oral
  • Intravenous

Regional Outlook:

North America accounted for the major share of the global Gastrointestinal Therapeutics Market Size Analysis in 2016 and will continue to rule the roost in the forecast period. The market for Gastrointestinal Therapeutics in North America, especially in the U.S., is the most lucrative one and gaining robust traction from numerous features such as changing lifestyle, resultant in grater occurrence of gastrointestinal diseases will upsurge the gastrointestinal therapeutics in North America region in the years to come.

Browse Related Category Research Reports @

Matched content

Editor’s pick

Express Press Release Distribution